Acrivon Therapeutics, Inc. ACRV
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-11-15
Acrivon Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 767,020 | $4.4M |
| RENAISSANCE TECHNOLOGIES LLC | 758,440 | $1.1M |
| TWO SIGMA INVESTMENTS, LP | 389,395 | $541,259 |
Source: SEC EDGAR filings · CIK 0001781174 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.